2011
DOI: 10.1016/j.bios.2010.03.001
|View full text |Cite
|
Sign up to set email alerts
|

Gene expression analysis with an integrated CMOS microarray by time-resolved fluorescence detection

Abstract: DNA microarrays have proven extraordinarily powerful for differential expression studies across thousands of genes in a single experiment. Microarrays also have the potential for clinical applications, including the detection of infectious and immunological diseases and cancer, if they can be rendered both reliable and cost-effective. Here we report the first practical application of an active microarray based on integrated circuit technology, completely obviating the need for external measurement instrumentat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
14
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 21 publications
(14 citation statements)
references
References 24 publications
0
14
0
Order By: Relevance
“…Because some of them are induced in isolated peripheral blood cells after exposure to doses as low as 5-25 mGy (Knops et al 2012;Riecke et al 2012;Manning et al 2013;Nosel et al 2013), it can be stated that in terms of sensitivity to low doses gene expression equals the DCA method. As a result, the development of a biodosimetry gene signature and associated assays which can be configured as devices suitable for low-cost, 'point-of-care' measurements make an appealing strategy (Brengues et al 2010;Huang et al 2011;Joiner et al 2011).…”
Section: Introductionmentioning
confidence: 99%
“…Because some of them are induced in isolated peripheral blood cells after exposure to doses as low as 5-25 mGy (Knops et al 2012;Riecke et al 2012;Manning et al 2013;Nosel et al 2013), it can be stated that in terms of sensitivity to low doses gene expression equals the DCA method. As a result, the development of a biodosimetry gene signature and associated assays which can be configured as devices suitable for low-cost, 'point-of-care' measurements make an appealing strategy (Brengues et al 2010;Huang et al 2011;Joiner et al 2011).…”
Section: Introductionmentioning
confidence: 99%
“…Several groups are developing gene expression signatures as an approach for emergency biodosimetry (7–9), while others are developing devices for implementing low-cost, rapid measurements in the field (18–21). Because of the diversity of gene expression responses to stresses such as ionizing radiation, it may be possible to develop such signatures to discriminate between acute and LDR exposures, either as part of a complete gene expression-based solution, or as an adjunct to a separate dose-determining approach such as high-throughput cytogenetics (22) or electron paramagnetic resonance measurements (23).…”
Section: Introductionmentioning
confidence: 99%
“…The choice of indicator RNA is essential for establishing the methodology to measure cellular damage. In this study, we used mRNAs of the well-known genes Bax , Bbc3 and Cdkn1a , which are considered biodosimetric indicators following low-dose irradiation in human [ 7 , 8 , 10 , 12 , 16 , 17 , 33 , 34 ] and mouse [ 20 ] cells. DNA damage by radiation in proliferative cells activates p53 protein via ATM signals, and then the p53 activates the growth-arrest protein CDKN1A and proapoptotic proteins BAX and BBC3 [ 35 ].…”
Section: Discussionmentioning
confidence: 99%